Pegasus Partners Ltd. Baxter International Inc Transaction History

Pegasus Partners Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$71.57 - $93.3 $332,299 - $433,191	-4,643 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$76.7 - $88.45 $208,163 - $240,053	-2,714 Reduced 36.89%	4,643 $388,000
Q3 2019 Oct 24, 2019	SELL	$81.4 - $89.78 $1.15 Million - $1.27 Million	-14,122 Reduced 65.75%	7,357 $644,000
Q2 2019 Jul 30, 2019	SELL	$73.44 - $82.41 $330,039 - $370,350	-4,494 Reduced 17.3%	21,479 $1.76 Million
Q1 2019 May 13, 2019	BUY	$64.48 - $81.31 $147,078 - $185,468	2,281 Added 9.63%	25,973 $2.11 Million
Q4 2018 Feb 01, 2019	SELL	$61.45 - $77.8 $428,798 - $542,888	-6,978 Reduced 22.75%	23,692 $1.56 Million
Q3 2018 Nov 07, 2018	BUY	$70.71 - $77.75 $117,449 - $129,142	1,661 Added 5.73%	30,670 $2.36 Million
Q2 2018 Jul 27, 2018	BUY	$63.43 - $75.41 $200,311 - $238,144	3,158 Added 12.22%	29,009 $2.14 Million
Q1 2018 May 09, 2018	BUY	$62.56 - $72.26 $308,671 - $356,530	4,934 Added 23.59%	25,851 $1.68 Million
Q4 2017 Feb 08, 2018	BUY	$61.45 - $66.05 $1.29 Million - $1.38 Million	20,917	20,917 $1.35 Million

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Pegasus Partners Ltd. with notifications on news.